Drawing for DOSSIER OF CLINICAL INFORMATION

USPTO serial 75440021

DOSSIER OF CLINICAL INFORMATION

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
ENGEL, MICHAEL
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DOSSIER OF CLINICAL INFORMATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and multi-lingual, interactive computer software for storage and retrieval of medical records and medical dataACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 11, 2000ABN1ABANDONMENT - EXPRESS MAILED
Jan 10, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 1999CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 29, 1999CNEAEXAMINER'S AMENDMENT MAILED
Jun 2, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 1998DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance